Daniel D. Burton - 01 Dec 2025 Form 4 Insider Report for Health Catalyst, Inc. (HCAT)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
03 Dec 2025, 16:16:52 UTC
Prior SEC filing
04 Sep 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Benjamin Landry, as Attorney-in-Fact

Key filing fact

Daniel D. Burton filed Form 4 for Health Catalyst, Inc. (HCAT) on 03 Dec 2025.

Key facts

  • This page summarizes Daniel D. Burton's Form 4 filing for Health Catalyst, Inc. (HCAT).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 03 Dec 2025, 16:16.

Change

  • Previous filing in this sequence was filed on 04 Sep 2025.
  • Current net transaction value: -$161,585.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001780980 Primary reporting owner

Burton Daniel D.

Relationship
Chief Executive Officer, Director
Address
C/O HEALTH CATALYST, INC., 10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Signature
/s/ Benjamin Landry, as Attorney-in-Fact
Signature date
03 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HCAT transaction

Common Stock

Tax liability

Transaction value
$161,585
Shares
-55,715
Change %
-3.8%
Price
$2.90
Shares after
1,393,099
Date
01 Dec 2025
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .